热门资讯> 正文
Immunocore错过第四季度盈利
2026-02-25 20:10
- Immunocore press release (IMCR): Q4 GAAP EPS of -$0.60 misses by $0.42.
- Revenue of $104.48M (+24.3% Y/Y) misses by $3.29M.
- Cash, cash equivalents and marketable securities of $864.2 million as of December 31, 2025.
More on Immunocore
- Immunocore Holdings plc (IMCR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Seeking Alpha’s Quant Rating on Immunocore
- Historical earnings data for Immunocore
- Financial information for Immunocore
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。